Cost-utility analysis of HTLV-1 antenatal screening: Open-access editable tool
Published: 8 June 2023| Version 2 | DOI: 10.17632/5wb25p9d5g.2
Contributors:
Carolina Rosadas de Oliveira, Kátia Senna, Milene Costa, , , , , , , , , , , , , , , Description
This is a cost-utility model to assess the implementation of HTLV-1 antenatal screening and intervention to prevent mother-to-child transmission (exclusive formula-feed). The model is based on a decision tree associated with a Markov model. This is available as an open-access, editable, user friendly, Microsoft Excel spreadsheet. Users can edit it with their input and the model will generate results automatically. Contact Dr. Carolina Rosadas for queries and support: c.rosadas-de-oliveira@imperial.ac.uk
Files
Steps to reproduce
More information at Rosadas et al 2023 Lancet Global Health
Institutions
Instituto Nacional de Cardiologia, Universidade Federal do Estado do Rio de Janeiro, Instituto de Infectologia Emilio Ribas, Universidade Estacio de Sa, Universidade de Sao Paulo Hospital das Clinicas, Centro de Pesquisas Goncalo Moniz, Universidade Federal do Rio de Janeiro, Imperial College London Faculty of Medicine, University of Birmingham, Universidade de Sao Paulo Faculdade de Medicina, Escola Bahiana de Medicina e Saude Publica
Categories
Infectious Disease, Virus, Cancer Prevention, Pregnancy, Transmission, Leukemia Prevention, Cost-Effectiveness Analysis, Cost-Utility Analysis, Economic Analysis, Antenatal Screening, Childhood